Cañete, Liezel .

HRN: 25-30-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2024
AMPICILLIN 1GM (VIAL)
06/17/2024
06/19/2024
IV
2gm
Q6 Until Delivery
Prom X 25hours
Waiting Final Action 
06/17/2024
CEFUROXIME 1.5GM (VIAL)
06/17/2024
06/18/2024
IV
1.5
Q8 X 3 Doses
S/P LTCS
Waiting Final Action 
06/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/17/2024
06/18/2024
IV
500mg
Q8 X 3 Doses
S/P LTCS
Waiting Final Action 
06/18/2024
CEFUROXIME 500MG (TAB)
06/18/2024
06/25/2024
PO
500 Mg Tab
BID
S/P LSCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: